Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

911
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
911
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers of Access to Gender-Affirming Health Care and Surgery: A Systematic Review.

Transgender health·2025
Same author

The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.

Annals of surgical oncology·2024
Same author

Risk Factors for Skin Flap and Nipple-Areolar Necrosis in Patients Undergoing Nipple-Sparing Mastectomy With Deep Inferior Epigastric Perforator Flap Reconstruction.

The American surgeon·2024
Same author

Robotic Repair: An Alternative Technique for Rectus Diastasis and Abdominal Bulge Following DIEP Flap Breast Reconstruction.

Aesthetic surgery journal·2024
Same author

A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness.

Psychopharmacology bulletin·2024
Same author

A Comprehensive Review of Lemborexant to Treat Insomnia.

Psychopharmacology bulletin·2024

Related Experiment Video

Updated: Jul 3, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.6K

Microsurgical breast reconstruction and primary hypercoagulable disorders.

Rakel M Zarb1, Charles Lamberton1, Aishwarya Ramamurthi1

  • 1Department of Plastic Surgery, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA.

Microsurgery
|February 12, 2024
PubMed
Summary

Microsurgical breast reconstruction is feasible for patients with primary hypercoagulability disorders. Extended low-molecular-weight heparin (LMWH) prophylaxis is safe, though flap salvage is challenging.

More Related Videos

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.2K
A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.3K

Related Experiment Videos

Last Updated: Jul 3, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

2.6K
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.2K
A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
12:24

A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice

Published on: January 23, 2016

9.3K

Area of Science:

  • Microsurgery
  • Plastic Surgery
  • Hematology

Background:

  • Primary hypercoagulable disorders present challenges in microsurgery, traditionally contraindicating free tissue transfer.
  • Free flaps offer advantages in breast reconstruction, necessitating expanded criteria for patient selection.
  • This study evaluates a chemoprophylaxis regimen for hypercoagulable patients undergoing breast reconstruction.

Observation:

  • A retrospective review included 15 patients (25 flaps) with primary hypercoagulability and 785 controls (1268 flaps).
  • Hypercoagulable conditions included Factor V Leiden mutation, Protein S deficiency, prothrombin mutation, and antiphospholipid syndrome.
  • Patients received extended low-molecular-weight heparin (LMWH) postoperatively.

Findings:

  • No significant difference in postoperative venous thromboembolism (VTE), mortality, hematoma, or transfusion rates compared to controls.
  • Flap loss rate was 4% in the hypercoagulable group versus 0.92% in controls (p=0.15).
  • Salvage rates for arterial or venous compromise were significantly lower in the hypercoagulable group (0% vs. 52%).

Implications:

  • Microsurgical breast reconstruction is feasible in hypercoagulable patients with acceptable flap loss rates.
  • Extended LMWH prophylaxis appears safe for this population.
  • Poor salvage potential highlights the need for careful patient selection and surgical technique.